- Information for Patients
- Information for Physicians
- Rosacea Review Newsletter
- Research Grants Program
- Classification of Rosacea
- Grading of Rosacea
- Management Options For Rosacea
- Glossary
- Join Us
- How to Donate
- Press Room
- Links
- Home
Archives
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
- August 2007
- July 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- October 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- February 2006
- January 2006
Links
Update on Angiogenesis
Wednesday, March 19, 2008
Results of two recent studies provide new understanding of how and when angiogenesis -- the formation of new blood vessels -- may contribute both to the initial development of rosacea and its persistent presence.
In a study of skin samples with and without rosacea, Dr. Amal Gomaa and colleagues at Boston University found evidence of angiogenesis in both the blood and lymphatic circulatory systems in skin with rosacea lesions. [1]
While the development of visible blood vessels, called telangiectasia, has long been recognized in rosacea, evidence of lymphatic vessel growth has not been previously reported, the researchers said. They also noted that study results suggested lymphatic involvement occurs at the beginning of the disease rather than later in its progress. The lymphatic circulatory system consists of vessels that carry a clear liquid that bathes the tissues of the body and may fight infection.
"Our study may highlight new players in the pathogenesis of rosacea," the researchers said in the article. They pointed out that the lymphatic angiogenesis was not expected as no patient had facial swelling, but that the findings support the long-held belief that the lymphatic system is involved in the process of skin inflammation.
The researchers also noted that increased expression of vascular endothelial growth factor (VEGF), which plays a role in angiogenesis, was found only in rosacea-affected skin samples. Interestingly, the study found no difference in VEGF levels between subtype 1 (erythematotelangiectatic) rosacea, characterized by facial redness, and subtype 2, (papulopustular) rosacea, characterized by bumps and pimples, which suggests that telangiectasia may be present in each.
In another study of affected and unaffected skin, Dr. Kyriaki Aroni and colleagues of the University of Athens studied the potential role of angiogenesis and mast cells in rosacea. [2]
"It seems increasingly possible that rosacea pathology is a multifactorial process, which opens up areas of research with regard to potential links between different contributing factors," the researchers said. Mast cells, connective tissue cells that release chemical substances in response to injury or allergic reaction, are known to augment inflammatory processes and occur in increased numbers in conditions associated with angiogenesis.
In their study of 69 rosacea patients, the researchers found that the number of mast cells was significantly higher in skin with rosacea, especially later in the disease, suggesting that the cells may be involved in the longer duration of rosacea. They pointed out that rhinophyma (enlargement of the nose), usually a later manifestation of rosacea, is also characterized by increased numbers of mast cells.
References
1. Gomaa AHA, Yaar M, Eyada MMK, Bhawan J. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. Journal of Cutaneous Pathology 2007;34:748-753.
2. Aroni K, Tsagroni E, Kavantzas N, Patsouris E, Ioannidis E. A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Archives of Dermatological Research DOI: 10.1007/s00403-007-08162.
Rosacea in Children
Thursday, March 6, 2008
Although rosacea rarely appears in children, its potential occurrence should be considered during medical examinations because of the possible severity of ocular (eye) involvement, according to a report in the February 2008 issue of the Archives of Dermatology. Researchers Dr. Mélanie Chamaillard and colleagues at the National Reference Center for Rare Skin Disorders, Bordeaux, France, suggested that an ophthalmologic (eye) examination be carried out for all children with skin signs of rosacea.
The signs and symptoms of ocular rosacea in children may be frequently underdiagnosed or misdiagnosed, the researchers said. They examined the records of 20 children with rosacea from 1½ to 14 years old, and noted that though most had minor ocular involvement, five had more serious eye manifestations that if undetected could lead to severe infection and visual impairment.
Reference
Chamaillard M, Mortemousque B, Boralevi F, Marques da Costa C, Aitali F, Taïeb A, Léauté-Labrèze C. Cutaneous and ocular signs of childhood rosacea. Archives of Dermatology 2008;144:167-171.
